Rowland Carmichael Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$968K Sell
17,748
-1,632
-8% -$85.3K 0.31% 77
2020
Q3
$968K Buy
19,380
+390
+2% +$18.9K 0.38% 71
2020
Q2
$838K Buy
+18,990
New +$812K 0.36% 70

Other funds holding IHI

Rowland Carmichael Advisors's IHI Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 8.4% in Q4 2020, selling an estimated $85.3K and leaving 17,748 shares worth $968K. The position accounts for 0.31% of the portfolio, ranked #77.

Rowland Carmichael Advisors first reported a position in IHI in Q2 2020 and has held it in 3 quarters since. 582 funds tracked by Wall St. Rank hold IHI as of Q4 2020.

  • Rowland Carmichael Advisors held 17,748 shares of iShares US Medical Devices ETF worth $968K as of Q4 2020.
  • Rowland Carmichael Advisors sold 1,632 iShares US Medical Devices ETF shares in Q4 2020, an estimated $85.3K.
  • iShares US Medical Devices ETF made up 0.31% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #77 holding.
  • Rowland Carmichael Advisors first reported a position in iShares US Medical Devices ETF in Q2 2020 and has held it in 3 quarters since.
  • 582 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.